CLINICAL MANIFESTATIONS OF POLYCYSTIC OVARY SYNDROME AT A LATE REPRODUCTIVE AGE AND IN POSTMENOPAUSE


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Objective. To def ine age-related changes in the clinical picture of polycystic ovary syndrome (POS). Subjects and methods. The study enrolled 60 POS patients aged over 40 years (38 patients at a late reproductive age and 22 in postmenopause). A control group comprised 197 women (mean age 52.8±7.2 years). All the patients underwent a clinical laboratory examination involving hormonal and biochemical (lipid fractions) studies and an oral glucose tolerance test. Results. TThe POS patients over aged 40 years were not found to have biochemical hyperandrogenism both at a late reproductive age and in menopause; type 2 diabetes mellitus (type 2 DM) and glucose tolerance were detected in a third (n=18) and every five (n=13) of patients, respectively; which is substantially higher than that in the comparison group stratified by body mass index and age. Obesity in POS makes an additional contribution, by increasing the risk of type 2 DM: odds ratio 5.58 (95% confidence interval 1.33-32.69). Conclusion. POS may be considered to be a powerful risk factor for carbohydrate metabolic disturbances. Obesity in POS is an additional risk factor and generally aggravates the course of the disease.

Full Text

Restricted Access

About the authors

T. V CHEBOTNIKOVA

Endocrinology Research Center, Ministry of Health and Social Development of Russia; Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia

Email: t-che@yandex.ru

G. N DAVYDOVA

Russian State Medical University, Russian Agency for Health Care

Department of Obstetrics and Gynecology, Faculty of Pediatrics

ZH. L KHOLODOVA

Russian State Medical University, Russian Agency for Health Care

Department of Obstetrics and Gynecology, Faculty of Therapeutics

A. V ILYIN

Endocrinology Research Center, Ministry of Health and Social Development of Russia

N. P GONCHAROV

Endocrinology Research Center, Ministry of Health and Social Development of Russia

I. I DEDOV

Endocrinology Research Center, Ministry of Health and Social Development of Russia

G. A MELNICHENKO

Endocrinology Research Center, Ministry of Health and Social Development of Russia

References

  1. Дедов И.И., Мельниченко Г.А., Чеботникова Т.В. и др. Распространенность и клиническая картина синдрома поликистозных яичников в популяции г.Москвы // Пробл. эндокринол. — 2010. — № 4. — С. 3—8.
  2. Balen A.N., Conway G.S. Polycystic ovary syndrome: A guide to clinical management. — London: Taylor and Francis, 2005.
  3. Dahlgren E., Johansson S., Lindstedt G. Women with PCOS wedge resected in 1956 to 1965: a long-term follow-up focusing on natural history and circulating hormones // Fertil. and Steril. — 1992. — Vol. 57, № 3. Р. 505—513.
  4. Ehrmann D.B., Barnes R.B. Prevalence of impaired glucose tolerance and diabetes in women with PCOS // Diabetes Care. — 1999. — Vol. 22, № 1. — Р. 141—146.
  5. Elting M.W., Korsen T.J., Rekers-Mombarg L.T., Schoemaker J. Women with polycystic ovary syndrome gain regular menstrual cycles when ageing // Hum. Reprod. — 2000. — Vol. 15, № 1. — Р. 24—28.
  6. Harris M.I., Hadden W.C., Knowler W.C. et al. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20—74 yr // Diabetes. — 1987. — Vol. 36, № 4. — Р. 523—534.
  7. Hatch R., Rosenfield R.L., Kim M.H. Hirsutism: implications, etiology, and management // Am. J. Obstet. Gynecol. — 1981. — Vol. 140, № 7. — Р. 815—830.
  8. Legro R.S., Kunselman A.R., Dodson W.C., Dunaif A. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women // J. Clin. Endocrinol. Metab. — 1999. — Vol. 84, N 1. — P. 165—169.
  9. Lobo R.A., Carmina E. The importance of diagnosing the polycystic ovary syndrome // Ann. Intern. Med. — 2000. — Vol. 132, № 12. — Р. 989—993.
  10. Pierpoint T., McKeigue P.M., Isaacs A.J. et al. Mortality of women with polycystic ovary syndrome at long-term follow-up // J. Clin. Epidemiol. — 1998. — Vol. 51, № 7. — Р. 581—586.
  11. The Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS) // Hum. Reprod. — 2004. — Vol. 19, № 1. — Р. 41—47.
  12. Salley K.E., Wickham E.P., Cheang K.I. Glucose intolerance in polycystic ovary syndrome - a position statement of the Androgen Excess Society // J. Clin. Endocrinol. Metab. — 2007. — Vol. 92, № 12. — Р. 4546—4556.
  13. Solomon C.G. The epidemiology of polycystic ovary syndrome. Prevalence and associated disease risks // Endocrinol. Metab. Clin. N. Am. — 1999 — Vol. 28, № 2. — Р. 247—263.
  14. Stein I.F., Leventhal M.L. Amenorrhea associated with bilateral polycystic ovaries // Am. J. Obstet. Gynecol. — 1935. — Vol. 29, № 3. — Р. 181—191.

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies